Tonix Pharma (TNXP) Misses Q2 EPS by 1405c

Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($19.28), $14.05 worse than the analyst estimate of ($5.23). Revenue for the quarter came in at $2.21 million versus the consensus estimate of $3.5 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• Eco Wave Power raises $4M in direct offering priced at premium
• Blue Owl Said To Be In Talks To Buy Stake In NBA's Cavaliers - Bloomberg